In-vivo generation of chimeric antigen receptor (CAR) T-cells using lipid nanoparticles to treat autoimmune kidney disease
Fields of Study & Subjects
CAR-T cell therapy research
RNA Interference and Gene Delivery
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 17 February 2026
- Language
- EN